CHDI Foundation
The CHDI Foundation, Inc., is a United States–based non-profit biomedical foundation that aims to "rapidly discover and develop drugs that delay or slow the progression of Huntington's disease", a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CHDI Foundation, United States, covering academic research published from 2005 to 2025. Read More.
Open Access Percentage
66%
Total
Publications
671
Total Open
Publications
445
Total
Citations
33K
Open Access
Percentage
66%
Total
Publications
671
Total Open
Publications
445
Total
Citations
33K
Breakdown
Publisher Open
11%
Both
31%
Other Platform Open
23%
Closed
35%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 57%
156
Hybrid 19%
51
No Guarantees 24%
67
Other Platform Open
Domain 71%
248
Institution 47%
165
Preprint 15%
51
Other Internet 14%
47
Public 8%
27
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 252 |
doaj.org OAI-PMH Repository | Institution | 76 |
DOI | Other Internet | 41 |
bioRxiv | Preprint | 33 |
Figshare | Public | 24 |
gla.ac.uk OAI-PMH Repository | Institution | 13 |
Europe PMC | Domain | 13 |
California Digital Library | Institution | 12 |
Monash University | Institution | 10 |
University College London | Institution | 9 |